Advisory Committees; Tentative Schedule of Meetings for 2008, 2507-2509 [E8-567]
Download as PDF
<![CDATA[
2507
Federal Register / Vol. 73, No. 10 / Tuesday, January 15, 2008 / Notices
Please note that in January 2008, the
FDA Web site is expected to transition
to the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. After the transition
date, electronic submissions will be
accepted by FDA through the FDMS
only. When the exact date of the
transition to FDMS is known, FDA will
publish a Federal Register notice
announcing that date.
Dated: January 7, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–571 Filed 1–14–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. 2007N–0240]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Patent Term Restoration, Due
Diligence Petitions, Filing, Format, and
Content of Petitions
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Patent Term Restoration, Due Diligence
Petitions, Filing, Format, and Content of
Petitions’’ has been approved by the
Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Karen L. Nelson, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
SUMMARY:
In the
Federal Register of October 11, 2007 (72
FR 57950), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0233. The
approval expires on January 31, 2011. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.fda.gov/
ohrms/dockets.
SUPPLEMENTARY INFORMATION:
Dated: January 9, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–573 Filed 1–14–08; 8:45 am]
Food and Drug Administration
AGENCY:
Lane, Rockville, MD 20857, 301–827–
4816.
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Tentative
Schedule of Meetings for 2008
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
tentative schedule of forthcoming
meetings of its public advisory
committees for 2008. During 1991, at the
request of the Commissioner of Food
and Drugs (the Commissioner), the
Institute of Medicine (the IOM)
conducted a study of the use of FDA’s
advisory committees. In its final report,
Committee Name
one of the IOM’s recommendations was
for the agency to publish an annual
tentative schedule of its meetings in the
Federal Register. This publication
implements the IOM’s recommendation.
FOR FURTHER INFORMATION CONTACT:
Theresa L. Green, Advisory Committee
Oversight and Management Staff (HF–
4), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,
301–827–1220.
The IOM,
at the request of the Commissioner,
undertook a study of the use of FDA’s
advisory committees. In its final report
in 1992, one of the IOM’s
recommendations was for FDA to adopt
a policy of publishing an advance yearly
schedule of its upcoming public
advisory committee meetings in the
Federal Register; FDA has implemented
this recommendation. The annual
publication of tentatively scheduled
advisory committee meetings will
provide both advisory committee
members and the public with the
opportunity, in advance, to schedule
attendance at FDA’s upcoming advisory
committee meetings. Because the
schedule is tentative, amendments to
this notice will not be published in the
Federal Register. However, changes to
the schedule will be posted on the FDA
advisory committees’ Internet site
located at https://www.fda.gov/oc/
advisory/default.htm. FDA will
continue to publish a Federal Register
notice 15 days in advance of each
upcoming advisory committee meeting,
to announce the meeting (21 CFR 14.20).
The following list announces FDA’s
tentatively scheduled advisory
committee meetings for 2008. You may
also obtain up-to-date information by
calling the Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area).
SUPPLEMENTARY INFORMATION:
Tentative Date of Meeting(s)
Advisory Committee
10-Digit Information
Line Code
OFFICE OF THE COMMISSIONER
Pediatric Advisory Committee
March and November days to be announced
8732310001
Risk Communication Advisory Committee
February 28–29, May 15–16, August 21–22, November
17–18
8732112560
Science Board to FDA
May and October days to be announced
3014512603
rwilkins on PROD1PC63 with NOTICES
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory Committee
April 29, October 17
3014512388
Blood Products Advisory Committee
May 1–2, August 14–15, December 11–12
3014519516
Cellular, Tissue and Gene Therapies Advisory Committee
April 10–11, November 13–14
3014512389
VerDate Aug<31>2005
17:48 Jan 14, 2008
Jkt 214001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
E:\FR\FM\15JAN1.SGM
15JAN1
2508
Federal Register / Vol. 73, No. 10 / Tuesday, January 15, 2008 / Notices
Committee Name
Tentative Date of Meeting(s)
Advisory Committee
10-Digit Information
Line Code
Transmissible Spongiform Encephalopathies Advisory
Committee
To be announced
3014512392
Vaccines and Related Biological Products Advisory Committee
February 20–21, May 21–22, September 24–25, November 19–20
3014512391
Anesthetic and Life Support Drugs Advisory Committee
March 11, May days to be announced
3014512529
Anti-Infective Drugs Advisory Committee
February 27–28, April 1–3
3014512530
Antiviral Drugs Advisory Committee
To be announced
3014512531
Arthritis Advisory Committee
July, September, and November days to be announced
3014512532
Cardiovascular and Renal Drugs Advisory Committee
June 24–25, August 19–20, December 9–10
3014512533
Dermatologic and Ophthalmic Drugs Advisory Committee
April days to be announced
3014512534
Drug Safety and Risk Management Advisory Committee
February 1, May days to be announced
3014512535
Endocrinologic and Metabolic Drugs Advisory Committee
April 16–17, July 1–2, October 29–30, November 19–20
3014512536
Gastrointestinal Drugs Advisory Committee
January 23, May days to be announced
3014512538
Nonprescription Drugs Advisory Committee
To be announced
3014512541
Oncologic Drugs Advisory Committee
March 13, April days to be announced, May 30, September 10–11, December 15–16
3014512542
Peripheral and Central Nervous System Drugs Advisory
Committee
May days to be announced
3014512543
Pharmaceutical Science and Clinical Pharmacology, Advisory Committee for
March 18–19
3014512539
Psychopharmacologic Drugs Advisory Committee
February 6
3014512544
Pulmonary-Allergy Drugs Advisory Committee
February 20
3014512545
Reproductive Health Drugs, Advisory Committee for
To be announced
3014512537
August 12, October 20–21
3014512398
CENTER FOR DRUG EVALUATION AND RESEARCH
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory Committee
Medical Devices Advisory Committee (Comprised of 18 Panels)
January 23, March 26, September 17
3014512624
Circulatory System Devices Panel
August 26–27, November 14–15
3014512625
Clinical Chemistry and Clinical Toxicology Devices Panel
April 9–10, August 13–14, December 4–5
3014512514
Dental Products Panel
June 11, September 10, November 19
3014512518
Ear, Nose, and Throat Devices Panel
April 16–17, June 25–26, August 28–29, October 28–29,
December 10–11
3014512522
Gastroenterology-Urology Devices Panel
October 17
3014512523
General and Plastic Surgery Devices Panel
June 10–11, October 21–22
3014512519
General Hospital and Personal Use Devices Panel
May 6–7, September 16–17
3014512520
Hematology and Pathology Devices Panel
rwilkins on PROD1PC63 with NOTICES
Anesthesiology and Respiratory Therapy Devices Panel
April 25, October 17
3014512515
Immunology Devices Panel
November 6–7
3014512516
Medical Devices Dispute Resolution Panel
To be announced as needed
3014510232
Microbiology Devices Panel
April 24–25, June 19–20, October 23–24
3014512517
VerDate Aug<31>2005
17:48 Jan 14, 2008
Jkt 214001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
E:\FR\FM\15JAN1.SGM
15JAN1
2509
Federal Register / Vol. 73, No. 10 / Tuesday, January 15, 2008 / Notices
Committee Name
Tentative Date of Meeting(s)
Advisory Committee
10-Digit Information
Line Code
Molecular and Clinical Genetics Panel
May 6–7, November 11–12
3014510231
Neurological Devices Panel
March 25–26, June 3–4, September 23–24, November 6–
7
3014512513
Obstetrics and Gynecology Devices Panel
April 17–18, June 19–20, August 14–15, October 16–17,
December 11–12
3014512524
Ophthalmic Devices Panel
February 21–22, May 15–16, September 18–19, November 20–21
3014512396
Orthopedic and Rehabilitation Devices Panel
April 21–22, June 16–17, August 18–19, October 20–21,
December 8–9
3014512521
Radiological Devices Panel
April 15–16, August 12, November 4
3014512526
National Mammography Quality Assurance Advisory Committee
October 13–14
3014512397
Technical Electronic Product Radiation Safety Standards
Committee
October 8
3014512399
July 22, December 2
3014510564
March day to be announced
3014512548
August 12–13
3014512559
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory Committee
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory Committee
National Center for Toxicological Research (NCTR)
Science Advisory Board to NCTR
Dated: January 7, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8–567 Filed 1–14–08; 8:45 am]
Dated: January 7, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8–490 Filed 1–14–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Fishers Lane, Rockville, MD 20857,
301–827–7001, FAX: 301–827–6776, email: Teresa.Watkins@fda.hhs.gov, or
FDA Advisory Committee Information
Line, 1–800–741–8138 (301–443–0572
in the Washington DC area), code
3014512535. Please call the Information
Line for up-to-date information on this
meeting.
Food and Drug Administration
SUPPLEMENTARY INFORMATION:
In the
Federal Register of December 11, 2007,
FDA announced that a meeting of the
Drug Safety and Risk Management
Advisory Committee would be held on
February 1, 2008. On page 70336, in the
second column, the first paragraph of
the Agenda portion of document is
amended to read as follows:
Agenda: The committee will discuss
the efficacy and safety of new drug
application (NDA) 22–054, INJECTAFER
(ferric carboxymaltose injection),
Luitpold Pharmaceuticals Inc., used for
the treatment of iron deficiency anemia
in postpartum patients or iron
deficiency anemia in patients with
heavy uterine bleeding.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
Health Resources and Services
Administration
BILLING CODE 4160–01–S
Drug Safety and Risk Management
Advisory Committee; Amendment of
Notice
AGENCY:
Food and Drug Administration,
HHS.
rwilkins on PROD1PC63 with NOTICES
ACTION:
Notice.
The Food and Drug Administration
(FDA) is announcing an amendment to
the notice of meeting of the Drug Safety
and Risk Management Advisory
Committee. This meeting was
announced in the Federal Register of
December 11, 2007 (72 FR 70336). The
amendment is being made to reflect a
change in the Agenda portion of the
document. There are no other changes.
FOR FURTHER INFORMATION CONTACT:
Teresa A. Watkins, Center for Drug
Evaluation and Research (HFD–21),
Food and Drug Administration, 5600
VerDate Aug<31>2005
17:48 Jan 14, 2008
Jkt 214001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notification of Exception to
Competition
Health Resources and Services
Administration, HHS.
AGENCY:
Notification of Exception to
Competition.
ACTION:
SUMMARY: The Health Resources and
Services Administration (HRSA) is
issuing a non-competitive program
expansion supplement to the National
Health Care for the Homeless Council
(NHCHC) to provide expanded training
and technical assistance to HRSAfunded grantees serving individuals
who are homeless.
Authority: This activity is under the
authority of the Public Health Service
Act, section 330(l).
E:\FR\FM\15JAN1.SGM
15JAN1
]]>Agencies
[Federal Register Volume 73, Number 10 (Tuesday, January 15, 2008)]
[Notices]
[Pages 2507-2509]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-567]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Tentative Schedule of Meetings for 2008
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a
tentative schedule of forthcoming meetings of its public advisory
committees for 2008. During 1991, at the request of the Commissioner of
Food and Drugs (the Commissioner), the Institute of Medicine (the IOM)
conducted a study of the use of FDA's advisory committees. In its final
report, one of the IOM's recommendations was for the agency to publish
an annual tentative schedule of its meetings in the Federal Register.
This publication implements the IOM's recommendation.
FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Advisory Committee
Oversight and Management Staff (HF-4), Food and Drug Administration,
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner,
undertook a study of the use of FDA's advisory committees. In its final
report in 1992, one of the IOM's recommendations was for FDA to adopt a
policy of publishing an advance yearly schedule of its upcoming public
advisory committee meetings in the Federal Register; FDA has
implemented this recommendation. The annual publication of tentatively
scheduled advisory committee meetings will provide both advisory
committee members and the public with the opportunity, in advance, to
schedule attendance at FDA's upcoming advisory committee meetings.
Because the schedule is tentative, amendments to this notice will not
be published in the Federal Register. However, changes to the schedule
will be posted on the FDA advisory committees' Internet site located at
https://www.fda.gov/oc/advisory/default.htm. FDA will continue to
publish a Federal Register notice 15 days in advance of each upcoming
advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory
committee meetings for 2008. You may also obtain up-to-date information
by calling the Advisory Committee Information Line, 1-800-741-8138
(301-443-0572 in the Washington, DC area).
------------------------------------------------------------------------
Advisory Committee
Tentative Date of 10-Digit
Committee Name Meeting(s) Information Line
Code
------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER
------------------------------------------------------------------------
Pediatric Advisory March and November days 8732310001
Committee to be announced
------------------------------------------------------------------------
Risk Communication February 28-29, May 15- 8732112560
Advisory Committee 16, August 21-22,
November 17-18
------------------------------------------------------------------------
Science Board to FDA May and October days to 3014512603
be announced
------------------------------------------------------------------------
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
------------------------------------------------------------------------
Allergenic Products April 29, October 17 3014512388
Advisory Committee
------------------------------------------------------------------------
Blood Products Advisory May 1-2, August 14-15, 3014519516
Committee December 11-12
------------------------------------------------------------------------
Cellular, Tissue and Gene April 10-11, November 13- 3014512389
Therapies Advisory 14
Committee
------------------------------------------------------------------------
[[Page 2508]]
Transmissible Spongiform To be announced 3014512392
Encephalopathies
Advisory Committee
------------------------------------------------------------------------
Vaccines and Related February 20-21, May 21- 3014512391
Biological Products 22, September 24-25,
Advisory Committee November 19-20
------------------------------------------------------------------------
CENTER FOR DRUG EVALUATION AND RESEARCH
------------------------------------------------------------------------
Anesthetic and Life March 11, May days to be 3014512529
Support Drugs Advisory announced
Committee
------------------------------------------------------------------------
Anti-Infective Drugs February 27-28, April 1- 3014512530
Advisory Committee 3
------------------------------------------------------------------------
Antiviral Drugs Advisory To be announced 3014512531
Committee
------------------------------------------------------------------------
Arthritis Advisory July, September, and 3014512532
Committee November days to be
announced
------------------------------------------------------------------------
Cardiovascular and Renal June 24-25, August 19- 3014512533
Drugs Advisory Committee 20, December 9-10
------------------------------------------------------------------------
Dermatologic and April days to be 3014512534
Ophthalmic Drugs announced
Advisory Committee
------------------------------------------------------------------------
Drug Safety and Risk February 1, May days to 3014512535
Management Advisory be announced
Committee
------------------------------------------------------------------------
Endocrinologic and April 16-17, July 1-2, 3014512536
Metabolic Drugs Advisory October 29-30, November
Committee 19-20
------------------------------------------------------------------------
Gastrointestinal Drugs January 23, May days to 3014512538
Advisory Committee be announced
------------------------------------------------------------------------
Nonprescription Drugs To be announced 3014512541
Advisory Committee
------------------------------------------------------------------------
Oncologic Drugs Advisory March 13, April days to 3014512542
Committee be announced, May 30,
September 10-11,
December 15-16
------------------------------------------------------------------------
Peripheral and Central May days to be announced 3014512543
Nervous System Drugs
Advisory Committee
------------------------------------------------------------------------
Pharmaceutical Science March 18-19 3014512539
and Clinical
Pharmacology, Advisory
Committee for
------------------------------------------------------------------------
Psychopharmacologic Drugs February 6 3014512544
Advisory Committee
------------------------------------------------------------------------
Pulmonary-Allergy Drugs February 20 3014512545
Advisory Committee
------------------------------------------------------------------------
Reproductive Health To be announced 3014512537
Drugs, Advisory
Committee for
------------------------------------------------------------------------
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
------------------------------------------------------------------------
Device Good Manufacturing August 12, October 20-21 3014512398
Practice Advisory
Committee
------------------------------------------------------------------------
Medical Devices Advisory Committee (Comprised of 18 Panels)
------------------------------------------------------------------------
Anesthesiology and January 23, March 26, 3014512624
Respiratory Therapy September 17
Devices Panel
------------------------------------------------------------------------
Circulatory System August 26-27, November 3014512625
Devices Panel 14-15
------------------------------------------------------------------------
Clinical Chemistry and April 9-10, August 13- 3014512514
Clinical Toxicology 14, December 4-5
Devices Panel
------------------------------------------------------------------------
Dental Products Panel June 11, September 10, 3014512518
November 19
------------------------------------------------------------------------
Ear, Nose, and Throat April 16-17, June 25-26, 3014512522
Devices Panel August 28-29, October
28-29, December 10-11
------------------------------------------------------------------------
Gastroenterology-Urology October 17 3014512523
Devices Panel
------------------------------------------------------------------------
General and Plastic June 10-11, October 21- 3014512519
Surgery Devices Panel 22
------------------------------------------------------------------------
General Hospital and May 6-7, September 16-17 3014512520
Personal Use Devices
Panel
------------------------------------------------------------------------
Hematology and Pathology April 25, October 17 3014512515
Devices Panel
------------------------------------------------------------------------
Immunology Devices Panel November 6-7 3014512516
------------------------------------------------------------------------
Medical Devices Dispute To be announced as 3014510232
Resolution Panel needed
------------------------------------------------------------------------
Microbiology Devices April 24-25, June 19-20, 3014512517
Panel October 23-24
------------------------------------------------------------------------
[[Page 2509]]
Molecular and Clinical May 6-7, November 11-12 3014510231
Genetics Panel
------------------------------------------------------------------------
Neurological Devices March 25-26, June 3-4, 3014512513
Panel September 23-24,
November 6-7
------------------------------------------------------------------------
Obstetrics and Gynecology April 17-18, June 19-20, 3014512524
Devices Panel August 14-15, October
16-17, December 11-12
------------------------------------------------------------------------
Ophthalmic Devices Panel February 21-22, May 15- 3014512396
16, September 18-19,
November 20-21
------------------------------------------------------------------------
Orthopedic and April 21-22, June 16-17, 3014512521
Rehabilitation Devices August 18-19, October
Panel 20-21, December 8-9
------------------------------------------------------------------------
Radiological Devices April 15-16, August 12, 3014512526
Panel November 4
------------------------------------------------------------------------
National Mammography October 13-14 3014512397
Quality Assurance
Advisory Committee
------------------------------------------------------------------------
Technical Electronic October 8 3014512399
Product Radiation Safety
Standards Committee
------------------------------------------------------------------------
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
------------------------------------------------------------------------
Food Advisory Committee July 22, December 2 3014510564
------------------------------------------------------------------------
CENTER FOR VETERINARY MEDICINE
------------------------------------------------------------------------
Veterinary Medicine March day to be 3014512548
Advisory Committee announced
------------------------------------------------------------------------
National Center for Toxicological Research (NCTR)
------------------------------------------------------------------------
Science Advisory Board to August 12-13 3014512559
NCTR
------------------------------------------------------------------------
Dated: January 7, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-567 Filed 1-14-08; 8:45 am]
BILLING CODE 4160-01-S
